Drug intelligence / Profile preview

Gynaeven

Development stage: Unknown
Lead developer: AVN Ayurveda Formulations
Administration: Oral

Overview

Gynaeven is a polyherbal Ayurvedic formulation developed by AVN Ayurveda Formulations for the management of women's reproductive health issues, specifically Polycystic Ovarian Syndrome (PCOS) and various menstrual disorders. It contains a blend of traditional Ayurvedic ingredients including *Saraca asoca* (Asoka), *Asparagus racemosus* (Shatavari), and *Symplocos racemosa* (Lodhra), along with Sukumaram kashayam and Pravala bhasmam. The formulation is designed to regulate the hypothalamo-pituitary-ovarian (HPO) axis, facilitating hormonal balance and correcting menstrual irregularities such as amenorrhea, anovulation, and scanty menstruation. It is also used to address female infertility associated with these conditions.

Brand names: GynaevenGynaven

Beyond the preview

Go deeper on Gynaeven.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gynaeven.

Explore the full profile